share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

福泰制药 | 4:持股变动声明-董事 SACHS BRUCE I
美股SEC公告 ·  05/24 16:19
Moomoo AI 已提取核心信息
On May 22, 2024, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 7,073 shares of common stock at a price of $448.00 per share. The transaction resulted in a total market value of $3,168,704. Following the sale, Sachs directly holds 40,000 shares of Vertex Pharmaceuticals. The sale was executed in the open market and is part of Sachs' direct holdings in the company. This financial activity reflects Sachs' latest dealings with Vertex Pharmaceuticals' stock, providing investors with updated insider transaction information.
On May 22, 2024, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 7,073 shares of common stock at a price of $448.00 per share. The transaction resulted in a total market value of $3,168,704. Following the sale, Sachs directly holds 40,000 shares of Vertex Pharmaceuticals. The sale was executed in the open market and is part of Sachs' direct holdings in the company. This financial activity reflects Sachs' latest dealings with Vertex Pharmaceuticals' stock, providing investors with updated insider transaction information.
2024年5月22日,与Vertex Pharmicals Inc.(VRTX)关联的布鲁斯一世萨克斯以每股448.00美元的价格完成了7,073股普通股的出售。该交易的总市值为3,168,704美元。出售后,萨克斯直接持有Vertex Pharmicals的40,000股股份。此次出售是在公开市场上进行的,是萨克斯在公司的直接持股的一部分。该财务活动反映了萨克斯与Vertex Pharmaceuticals股票的最新交易,为投资者提供了最新的内幕交易信息。
2024年5月22日,与Vertex Pharmicals Inc.(VRTX)关联的布鲁斯一世萨克斯以每股448.00美元的价格完成了7,073股普通股的出售。该交易的总市值为3,168,704美元。出售后,萨克斯直接持有Vertex Pharmicals的40,000股股份。此次出售是在公开市场上进行的,是萨克斯在公司的直接持股的一部分。该财务活动反映了萨克斯与Vertex Pharmaceuticals股票的最新交易,为投资者提供了最新的内幕交易信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息